Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthetic route for Teriparatide Impurity F achieving 92% purity. Optimized solid-phase peptide synthesis for reliable pharmaceutical intermediate supply and cost reduction.
Patent CN105543186A reveals novel biocatalytic route for high-purity chiral alcohols. Enables cost reduction in chiral alcohol manufacturing and supply chain reliability.
Patent CN105543186A enables high-purity chiral alcohol production with reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN118530280A details novel palladium ligands for acrylate synthesis offering high selectivity and supply chain stability for global pharmaceutical manufacturers.
Patent CN103304491A offers a safer, shorter route for Gefitinib intermediates, reducing environmental impact and manufacturing costs significantly.
Patent CN107382990B reveals a novel 3-step synthesis for potent AChE inhibitors. Discover cost-effective manufacturing strategies for this pharmaceutical intermediate.
Patent CN111320535B reveals a low-cost route for 3-(benzyloxy)-1-cyclobutanone using Hunsdiecker reaction, offering significant supply chain advantages for API manufacturing.
Patent CN1422843A reveals a mild one-step route from acid chlorides, offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Patent CN116904411A reveals mutant enzyme for efficient (R)-citronellal synthesis. Offers high ee value and conversion for reliable flavor and fragrance supplier needs.
Patent CN113666800B details a scalable synthesis method for 4-pentyne-1-ol offering high purity and reduced liquid ammonia usage for reliable pharmaceutical intermediate supply chains.
Novel two-step synthesis for Pomalidomide ensures high purity and cost efficiency. Reliable supply chain for pharmaceutical intermediates with scalable production.
Patent CN105732660B reveals a low-toxicity hydrolysis method for levofloxacin intermediate, ensuring high purity and supply chain stability for pharmaceutical manufacturers.
Patent CN114456088A details a novel ethanol-based purification for Etoricin, removing amide impurities to ensure high-purity UV absorber manufacturing and supply chain stability.
Novel CuI-catalyzed method for 1,4-diaryl-1,3-butadiynes offers mild conditions and cost efficiency for liquid crystal and agrochemical intermediate manufacturing.
Novel Boc-protection method for high-purity rhodamine B derivatives. Optimized for scalable fluorescent probe manufacturing and cost-effective supply chain solutions.
Novel one-pot synthesis reduces costs and improves supply chain reliability for high-purity pharmaceutical intermediates using mild reaction conditions.
Patent CN107235886A reveals metal-free phosphine catalysis for 2 3-dihydropyrrole rings enabling cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN104447697A reveals a novel enzymatic route for Dabigatran intermediates, offering high purity and cost-effective supply chain solutions for global pharmaceutical manufacturers.
Patent CN109796368B details a safer, cost-effective synthesis of Posaconazole intermediates using recyclable Pd/BaSO4 catalysts, eliminating hazardous DIBAL-H reagents.
Novel McMurry coupling route for ospemifene intermediates ensures high purity and scalable manufacturing for global supply chains.